Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02998047 |
| Title | A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Actinium Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA | Los Angeles | California | 90095 | United States | Details | |
| University Of Kansas Medical Center | Kansas City | Kansas | 66205 | United States | Details | |
| Memorial Sloan Kettering Cancer CEnter | New York | New York | 10065 | United States | Details | |
| Baylor Scott and White Research Institute, Charles A. Sammons Cancer Center | Dallas | Texas | 75246 | United States | Details | |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | United States | Details |